In an acute pancreatitis animal model, PS has been reported to reduce serum levels of TNFα/IL-1β and decrease the NF-κB gene expression in a dose-dependent manner, leading to attenuate the severe acute pancreatitis-induced tissue damage by decreasing the inflammatory response and protection of pancreatic tissues [96]. This evidence concerns the gene NFKB1 and acute pancreatitis.